Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion

Clinical trial NCT07482605 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07482605
Sponsor: Jiangmen Central Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer (NSCLC)Malignant Pleural Effusions (Mpe)- Pleurodesis

Start date: 2026-07-01
Primary completion: 2027-10-30
Enrollment: 63

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.